Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP622180.RAGPJwi-pJerjoi54qy53ewpkXWkc9yLHOKzJYHN7yEL0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP622180.RAGPJwi-pJerjoi54qy53ewpkXWkc9yLHOKzJYHN7yEL0130_assertion type Assertion NP622180.RAGPJwi-pJerjoi54qy53ewpkXWkc9yLHOKzJYHN7yEL0130_head.
- NP622180.RAGPJwi-pJerjoi54qy53ewpkXWkc9yLHOKzJYHN7yEL0130_assertion wasGeneratedBy ECO_0000203 NP622180.RAGPJwi-pJerjoi54qy53ewpkXWkc9yLHOKzJYHN7yEL0130_provenance.
- NP622180.RAGPJwi-pJerjoi54qy53ewpkXWkc9yLHOKzJYHN7yEL0130_assertion wasDerivedFrom befree-2016 NP622180.RAGPJwi-pJerjoi54qy53ewpkXWkc9yLHOKzJYHN7yEL0130_provenance.
- NP622180.RAGPJwi-pJerjoi54qy53ewpkXWkc9yLHOKzJYHN7yEL0130_assertion SIO_000772 17659339 NP622180.RAGPJwi-pJerjoi54qy53ewpkXWkc9yLHOKzJYHN7yEL0130_provenance.
- NP622180.RAGPJwi-pJerjoi54qy53ewpkXWkc9yLHOKzJYHN7yEL0130_assertion evidence source_evidence_literature NP622180.RAGPJwi-pJerjoi54qy53ewpkXWkc9yLHOKzJYHN7yEL0130_provenance.
- NP622180.RAGPJwi-pJerjoi54qy53ewpkXWkc9yLHOKzJYHN7yEL0130_assertion description "[The discovery of apoptotic pathways that can be manipulated by proteasome inhibition provides rationale for the combination of bortezomib and agents such as TRAIL in CHL treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP622180.RAGPJwi-pJerjoi54qy53ewpkXWkc9yLHOKzJYHN7yEL0130_provenance.